A high rate of broad-spectrum-␤-lactamase-producing Escherichia coli isolates was identified from seagull and pelican feces collected in the Miami Beach, Florida, area. The most commonly identified resistance determinants were CMY-2 and CTX-M-15. Those wild birds might be therefore considered vehicles for wide dissemination of multidrug-resistant Enterobacteriaceae in the United States.
C
ephalosporin resistance in Escherichia coli is mostly mediated by production of extended-spectrum ␤-lactamases (ESBL) and plasmid-mediated AmpC-type cephalosporinases (15) . During the past decade, CTX-M enzymes have been of growing importance worldwide, being reported widely in Enterobacteriaceae isolates recovered among humans (13, 14) either from community (E. coli) or nosocomial (Klebsiella pneumoniae) sources. In addition, CTX-M-positive E. coli has been identified in pets (4), in poultry (11) , in cattle (20, 23) , in retail meat (1, 20) , and in wild animals (7) , raising concerns regarding the transfer of ESBL between humans and animals. Among Enterobacteriaceae, CMY-2-type enzymes are the most commonly encountered plasmid-mediated AmpC-type ␤-lactamases worldwide and are involved in human hospital-or community-acquired infections (2, 24) but are also identified in isolates from cattle (8) or from retail meat (9) . It has also been reported that seagulls might be a reservoir of multidrug-resistant bacteria (19, 21) .
The objective of the study was to evaluate the occurrence of broad-spectrum-ß-lactam resistance determinants among Enterobacteriaceae recovered from wild bird feces collected at Miami Beach, Florida.
In April 2010, 53 fecal samples of wild seagulls (Larus delawarensis) and 10 fecal samples of pelicans were collected using a sterile spatula at different places on the shoreline of Miami Beach, Florida. Care was taken during sampling to avoid collection of beach sediment. Samples were placed in sterile tubes and processed in the laboratory. Samples were precultured in buffered peptone water (BPW) (Oxoid, Basingstoke, United Kingdom) at a dilution of 1/10 (wt/vol) and incubated at 37°C. Cultures were inoculated by streaking 10 l of the suspensions onto ChromID ESBL agar (bioMérieux), which selects for broad-spectrum-cephalosporin-resistant isolates. The plates were incubated at 37°C overnight, and identification of Enterobacteriaceae isolates was performed by using an API20E system (bioMérieux, Marcy l'Etoile, France). Susceptibility testing was performed by disk diffusion assay (Sanofi-Diagnostic Pasteur, Marnes-la-Coquette, France), as previously described (11) . ESBL production was confirmed by a synergy test using disks containing cefotaxime and ticarcillin-clavulanate, and production of AmpC was evidenced by using Mueller-Hinton (MH) plates supplemented with cloxacillin (200 g/ml) (11) . The MICs were determined by Etest (AB bioMérieux, Solna, Sweden) on MH agar plates at 37°C (6) . A total of 10 Enterobacteriaceae isolates displaying an ESBL phenotype were obtained from eight (14%) feces samples. All ESBL-producing isolates were resistant to ceftazidime and cefotaxime; all of them remained susceptible to carbapenems. Coresistances identified among the 10 ESBL-positive isolates were as follows: 70% were resistant to tetracycline, 80% to trimethoprim-sulfamethoxazole, 90% to nalidixic acid, 70% to ciprofloxacin, 60% to gentamicin, and 10% to chloramphenicol. Sixteen (29%) E. coli isolates displaying an AmpC-type phenotype were additionally identified. Among them, 44% were resistant to tetracycline, 25% to trimethoprim-sulfamethoxazole, 44% to nalidixic acid, 37% to ciprofloxacin, 19% to gentamicin, and 25% to chloramphenicol.
Detection of AmpC and ESBL genes was carried out by PCR (11). The purified PCR products were sequenced on both strands on an Applied Biosystems sequencer (ABI 377) and analyzed in the BLAST database (www.ncbi.nlm.nih.gov/blast/Blast.cgi). Eight of 10 (80%) ESBL producers were identified as E. coli and carried a bla CTX-M -like gene, whereas two Enterobacter cloacae isolates (n ϭ 2 [20%]) possessed a bla SHV-7 gene. PCR and sequencing identified the CTX-M ESBL determinants as CTX-M-15 (n ϭ 5 [50%]), CTX-M-32 (n ϭ 2 [20%]), and a variant of CTX-M-2 (n ϭ 1 [10%]), namely, CTX-M-124 (GenBank accession number JQ429324), which was identified as KluA-1 in Kluyvera ascorbata. All of the E. coli isolates displaying an AmpC-type phenotype produced the CMY-2 ␤-lactamase (Table 1) . Only one AmpC-producing K. pneumoniae isolate, possessing the FOX-5-encoding gene, was identified. None of the isolates coproduced AmpC and ESBL enzymes.
Clonal diversity was assessed by pulsed-field gel electrophoresis (PGFE) as described previously (11) . PGFE analysis showed a high diversity of genotypes (data not shown): 10 clones for 16 CMY-2-positive isolates, 4 clones for 5 CTX-M-15-positive iso-lates, 2 clones for 2 CTX-M-32-positive isolates, and 1 clone for 2 SHV-7-positive E. cloacae isolates ( Table 1) .
E. coli strains can be classified into four phylogenetic groups (A, B1, B2, and D). The virulent extraintestinal isolates belong mostly to group B2 and, to a lesser extent, to group D, whereas most commensal strains belong to groups A and B1 (5, 18) . Phylogenetic grouping of E. coli isolates was determined by PCR as described previously (5) . A total of 25% of the ESBL-positive E. coli strains and 63% of the CMY producers belonged to virulent extraintestinal E. coli group D. In contrast, 75% of the ESBL-producing and 25% of the CMY-producing E. coli strains belonged to phylogenetic group A, whereas 12% of the CMY-2 producers belonged to group B1, with both those latter groups corresponding to commensal strains ( Table 1) .
The MLST typing of the E. coli isolates was determined by sequencing seven essential genes (adk, fumC, icd, purA, gyrB, recA, and mdh) as described previously (22), followed by an analysis performed using the E. coli MLST web site (http://mlst.ucc.ie/mlst /dbs/Ecoli/). MLST typing identified 16 different types among the 24 E. coli isolates ( Table 1 ). The most commonly identified genotypes were ST963 (n ϭ 6), ST38 (n ϭ 2), ST617 (n ϭ 2), ST167 (n ϭ 2), and ST68 (n ϭ 2), whereas isolates belonging to the ST559, ST1845, ST10, ST853, ST405, ST410, ST648, ST540, ST162, and ST224 genotypes were also identified. Different genotypes carrying the same ESBL determinant or CMY-2 were identified, and all the ST963 isolates produced CMY-2.
Analysis of plasmid content was performed for the isolates that tested positive for bla CTX-M -like and bla CMY -like genes as described previously (11) . Incompatibility groups of ESBL-and CMY-positive plasmids were determined by PCR-based replicon typing as described previously (3) . Interestingly, plasmid analysis performed on E. coli isolates always identified large plasmids for either the bla CTX-M -or bla CMY -positive isolates (data not shown). In addition, the majority of bla CMY-2 -positive plasmids belonged to the IncI1 incompatibility group (n ϭ 11 [69%]), whereas the bla CTX-M -positive plasmids mainly belonged to the IncF incompatibility group (n ϭ 5 [50%]) ( Table 1 ). The two bla SHV-7 -positive plasmids identified in two E. cloacae isolates belonged to the IncL/M group (Table 1) .
Currently, infections with ESBL-producing bacilli occur not only in health care facilities but also in the community (16) . Previous studies have reported multidrug resistance in wild birds (19, 21) . The present report provides additional clues indicating that wild seagulls are carriers of ESBL-producing E. coli, as previously demonstrated in Europe (19, 21) . We report here that the CTX-M-1 group (including ß-lactamases CTX-M-1, CTX-M-15, and CTX-M-32) was the main CTX-M group identified among birds residing on the coastline of Miami Beach, which mirrors previous findings corresponding to studies performed on the beaches of Porto, Portugal (21) . This result fits also with the high prevalence of CTX-M-15 in community hospitals in the United States (16) . Interestingly, this study reports a high proportion (29%) of CMYpositive E. coli strains among wild seagulls of Miami Beach, which correlated well with the high prevalence of the bla CMY-2 gene among clinical or veterinary isolates (2, 8, 9, 24) . It is noteworthy that the bla CMY-2 gene was mostly located on the IncI1 plasmid, as reported previously (10, 12) . The IncA/C plasmid, known to be widely associated with the bla CMY-2 gene (12), was interestingly not identified in this study. ISEcp1 was associated with most of the CTX-M-and CMY-positive isolates, highlighting the role of this insertion sequence in the dissemination of various ␤-lactamase genes, as previously described (2) . Previous studies have reported the association of E. coli isolates of groups B2 and D with extraintestinal infections (18) . No ESBL isolate belonged to those groups, whereas 63% of all CMY isolates belong to the D phylogroup. We did not identify E. coli strains with the ST131 type known to be frequently isolated in humans and frequently associated with CTX-M-15 (16) . However, we identified here E. coli strains displaying ST10, ST38, ST405, ST617, and ST648, which were reported recently as the major sequence types among ESBL-producing E. coli strains involved in bacteremia in Canada (17) . This report suggests that beaches may play a significant role for dissemination of various resistance determinants and may be a source of CTX-M-15-or CMY-related community-acquired infections. The role of wild birds traveling along the east coast of North America might therefore play a role in the dissemination of multidrug-resistant E. coli and E. cloacae strains.
Nucleotide sequence accession number. The sequence of CTX-M-124 has been deposited in GenBank under accession number JQ429324.
